Alife Health Receives FDA Clearance for AI-Powered Embryo Assessment

Alife Health Receives FDA Clearance for AI-Powered Embryo Assessment

Alife Health Receives FDA Clearance for AI-Powered Embryo Assessment

Alife in the news

Alife Health Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2024

NEWS

March 19th, 2024

How AI Could Help Make The IVF Process Easier

NEWS

March 18th, 2024

Alabama Ruling Adds Regulatory Risk for IVF Startups

NEWS

February 27th, 2024

Partnership to Pilot ‘Cutting-Edge’ Embryo Selection Tool

NEWS

February 7th, 2024

AI Is Learning How To Help Pick Embryos for IVF

NEWS

November 7th, 2023

What Goes into Building an AI Company in the IVF Space

PODCAST

September 24th, 2023

Alife announcements

FutureLife becomes first European fertility network to adopt an end-to-end AI fertility platform, in partnership with Alife Health

May 5th, 2026

Alife Health Receives CE Mark Under European Medical Device Regulation for Embryo Predict™, Its AI-Powered Embryo Selection Tool

October 23rd, 2025

Gradient Orb

Gradient Orb

For all press inquiries, contact us at press@alifehealth.com

Company

Overview

Team

Career

Book a demo

Customer Support

Patents

Products

Platform Overview

Embryo Predict

Schedule Predict

Success Predictor

Resources

Research

Press & News

Customer Stories

For Patients

Alife App

Blog

IVF Calculator

Sign up for our newsletter for the latest advancements in fertility care.

©2026 by Alife Health

Terms

Privacy

App Privacy

Security

Cookie Declaration

[website version: 740-00200-REC-01 Rev 2]